eMedCodes logo

Rituxan - rituximab

Navigation: NDC > Supplier starting with: G > GENENTECH, INC.
Field Value
NDC Code: 50242-051
Proprietary Name: Rituxan
Suffix:
Non-Proprietary Name: rituximab
Dosage Form: INJECTION, SOLUTION
Method: INTRAVENOUS
Original Marketing Date: 26-11-1997
Category Name: BLA
Application Number: BLA103705
Labeler: GENENTECH, INC.
Substance Name: RITUXIMAB
Active Numerator Strength: 10
Active Ingredient Unit: mg/mL
Pharm Classes: CD20-directed Antibody Interactions [MoA],CD20-directed Cytolytic Antibody [EPC]
DEA Schedule: